Hospital-acquired C. diff comes with a financial price tag

August 5, 2019

A recent study has found at Clostridioides difficile (C. diff) comes with costs, as well as increased hospital stays, when the infection is acquired in the hospital, according to an article on the MD website.

In the study, investigators examined adult patients both with hospital-acquired C. Diff and without between April 1, 2012 and March 31, 2016.

The team estimated the cost of C. diff to be about $5.4 billion in the US, $4.7 billion of which was incurred in healthcare settings, mostly due to hospitalizations and recurrence.

The average healthcare cost for patients with the C. diff infection was $43,718 compared to $19,513 for those patients without.

Read the article.

See the latest posts on our homepage


Topic Area: Infection Control

Recent Posts
Recent Posts

‘Playbook’ preps Rhode Island healthcare facilities for power outages

'Protecting Patients When Disaster Strikes' describes the before-during-after of a power outage


Focus: Interior Design

Recognized interior designs include inviting, warm spaces

The International Interior Design Association announces the winners of the 2016 Healthcare Interior Design Competition


Medpricer’s mSource Insights Integrates AI, Spend Analytics and Visualization with Purchased Services Reporting


NYSID Announces Lineup for Fall 2019 Public Programs


Aspirus Announces Stevens Point Campus Expansion


Post Comment


News & Updates • Webcast Alerts • Building Technologies

All fields are required.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.